Karyopharm Therapeutics, Inc. (KPTI)
8.58
-0.36
(-4.03%)
USD |
NASDAQ |
Feb 13, 16:00
8.60
+0.02
(+0.23%)
After-Hours: 20:00
Karyopharm Therapeutics Free Cash Flow : -89.30M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Baxter International, Inc. | 323.00M |
| Bruker Corp. | 43.30M |
| Catalyst Pharmaceuticals, Inc. | 234.54M |
| Agios Pharmaceuticals, Inc. | -377.29M |
Free Cash Flow Related Metrics
| Free Cash Flow Per Share (Quarterly) | -0.676 |
| Free Cash Flow to Equity (Quarterly) | -11.66M |
| Free Cash Flow to Firm (Quarterly) | 5.159M |
| Free Cash Flow Yield | -95.35% |